177 related articles for article (PubMed ID: 35061511)
1. Interleukin-18 Plays a Positive Feedback Activity to Natural Killer-Like B Cells in Hepatitis B Virus-Associated Acute-on-Chronic Liver Failure.
Liu Y; Meng X; Wang C; Zhang Y; Hua WW; Wang Z
Viral Immunol; 2022; 35(1):50-59. PubMed ID: 35061511
[TBL] [Abstract][Full Text] [Related]
2. Natural Killer Group 2A Expressed on Both Peripheral CD3
Yi RT; Niu YH; Liu HL; Zhang TY; Yang YC; Zhang Y; Yin DL; Chen TY; Zhao YR
J Interferon Cytokine Res; 2016 Dec; 36(12):689-697. PubMed ID: 27828717
[TBL] [Abstract][Full Text] [Related]
3. Cytokines elevated in patients with HBV-related acute-on-chronic liver failure promote NK cell mediated cytotoxicity through TRAIL.
Wan Z; Xie G; Wu Y; Liu F; Xin S; You S; Liu H; Li C; Li D
Dig Liver Dis; 2016 May; 48(5):528-535. PubMed ID: 26860239
[TBL] [Abstract][Full Text] [Related]
4. NKP30-B7-H6 Interaction Aggravates Hepatocyte Damage through Up-Regulation of Interleukin-32 Expression in Hepatitis B Virus-Related Acute-On-Chronic Liver Failure.
Zou Y; Bao J; Pan X; Lu Y; Liao S; Wang X; Wang G; Lin D
PLoS One; 2015; 10(8):e0134568. PubMed ID: 26241657
[TBL] [Abstract][Full Text] [Related]
5. Serum Interleukin (IL)-9 and IL-10, but not T-Helper 9 (Th9) Cells, are Associated With Survival of Patients With Acute-on-Chronic Hepatitis B Liver Failure.
Yu X; Zheng Y; Deng Y; Li J; Guo R; Su M; Ming D; Lin Z; Zhang J; Su Z
Medicine (Baltimore); 2016 Apr; 95(16):e3405. PubMed ID: 27100428
[TBL] [Abstract][Full Text] [Related]
6. Role of interleukin-23 in monocyte-derived dendritic cells of HBV-related acute-on-chronic liver failure and its correlation with the severity of liver damage.
Bao S; Zheng J; Li N; Huang C; Chen M; Cheng Q; Li Q; Lu Q; Zhu M; Ling Q; Yu K; Chen S; Shi G
Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):147-155. PubMed ID: 28041935
[TBL] [Abstract][Full Text] [Related]
7. Increased Circulating T Follicular Helper Cells Induced
Du B; Teng J; Yin R; Tian Y; Jiang T; Du Y; Cai W
Front Immunol; 2021; 12():641362. PubMed ID: 33868273
[TBL] [Abstract][Full Text] [Related]
8. [Significance of triggering receptor expressed on myeloid cells-2 prognostic evaluation in hepatitis B virus-related acute-on-chronic liver failure].
Chen SL; Li XP; Gao L; Che YM; Zhang LL; Cheng XY
Zhonghua Gan Zang Bing Za Zhi; 2023 Dec; 31(12):1306-1312. PubMed ID: 38253075
[No Abstract] [Full Text] [Related]
9. Lower number and decreased function of natural killer cells in hepatitis B virus related acute-on-chronic liver failure.
Liu F; Duan X; Wan Z; Zang H; You S; Yang R; Liu H; Li D; Li J; Zhang Y; Xin S
Clin Res Hepatol Gastroenterol; 2016 Nov; 40(5):605-613. PubMed ID: 27053076
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 upregulates Th17 response via mTOR/STAT3 pathway in acute-on-chronic hepatitis B liver failure.
Kim HY; Jhun JY; Cho ML; Choi JY; Byun JK; Kim EK; Yoon SK; Bae SH; Chung BH; Yang CW
J Gastroenterol; 2014 Aug; 49(8):1264-73. PubMed ID: 24366287
[TBL] [Abstract][Full Text] [Related]
11. Lower level of complement component C3 and C3a in the plasma means poor outcome in the patients with hepatitis B virus related acute-on-chronic liver failure.
Li Q; Lu Q; Zhu MQ; Huang C; Yu KK; Huang YX; Zhao X; Luo XG; Zheng JM
BMC Gastroenterol; 2020 Apr; 20(1):106. PubMed ID: 32293297
[TBL] [Abstract][Full Text] [Related]
12. Treg/Th17 Cell Balance in Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure at Different Disease Stages.
Tan NH; Chen B; Peng J; Du S
Biomed Res Int; 2021; 2021():9140602. PubMed ID: 34869773
[TBL] [Abstract][Full Text] [Related]
13. [Correlation between interleukin-6 single nucleotide polymorphism and the occurrence and prognosis of hepatitis B virus-associated acute-on-chronic liver failure].
Lin YH; Lin S; Zhou Q; Wang MF; Zhu YY
Zhonghua Gan Zang Bing Za Zhi; 2019 Apr; 27(4):250-255. PubMed ID: 31082334
[No Abstract] [Full Text] [Related]
14. N-myc and STAT interactor correlates with severity and prognosis in acute-on-chronic liver failure of hepatitis B virus.
Xiong L; Du Y; Zhou T; Du B; Visalath P; Lin L; Bao S; Cai W
J Gastroenterol Hepatol; 2019 Oct; 34(10):1800-1808. PubMed ID: 30771232
[TBL] [Abstract][Full Text] [Related]
15. Increased Th17 cells and interleukin-17 contribute to immune activation and disease aggravation in patients with chronic hepatitis B virus infection.
Yang B; Wang Y; Zhao C; Yan W; Che H; Shen C; Zhao M
Immunol Lett; 2013 Jan; 149(1-2):41-9. PubMed ID: 23237940
[TBL] [Abstract][Full Text] [Related]
16. The Transforming Growth Factor β1/Interleukin-31 Pathway Is Upregulated in Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure and Is Associated with Disease Severity and Survival.
Yu X; Guo R; Ming D; Deng Y; Su M; Lin C; Li J; Lin Z; Su Z
Clin Vaccine Immunol; 2015 May; 22(5):484-92. PubMed ID: 25716231
[TBL] [Abstract][Full Text] [Related]
17. Increased interleukin-23 receptor (IL-23R) expression is associated with disease severity in acute-on-chronic liver failure.
Khanam A; Trehanpati N; Sarin SK
Liver Int; 2019 Jun; 39(6):1062-1070. PubMed ID: 30506912
[TBL] [Abstract][Full Text] [Related]
18. Persistently elevated circulating Th22 reversely correlates with prognosis in HBV-related acute-on-chronic liver failure.
Mo R; Wang P; Lai R; Li F; Liu Y; Jiang S; Zhao G; Guo S; Zhou H; Lin L; Lu J; Cai W; Wang H; Yu H; Bao S; Xiang X; Xie Q
J Gastroenterol Hepatol; 2017 Mar; 32(3):677-686. PubMed ID: 27548078
[TBL] [Abstract][Full Text] [Related]
19. Reduction of natural killer cells is associated with poor outcomes in patients with hepatitis B virus-related acute-on-chronic liver failure.
Li HJ; Yang N; Mu X; Tang L; Wang SS; Zhou CB; Yuan JH; Wang HY; Yu YY; Li J; Chen SY; Feng ZQ; Yang T; Liu K; Cao WJ; Zhou MJ; Zhang C; Zhang JY; Jiao YM; Song JW; Fan X; Shi M; Xu R; Wang FS
Hepatol Int; 2022 Dec; 16(6):1398-1411. PubMed ID: 36109429
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-24 Limits Tumor-Infiltrating T Helper 17 Cell Response in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma.
Zhang M; Zhao H; Gao H
Viral Immunol; 2022 Apr; 35(3):212-222. PubMed ID: 35099297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
